期刊文献+

MicroRNA-200a/TFAM通路调控紫杉醇对乳腺癌细胞的化疗敏感性 被引量:4

The Function of Paclitaxel on the Breast Cancer Cells Chemosensitivity by Regulating MicroRNA-200a/TFAM Pathway
下载PDF
导出
摘要 目的探讨MicroRNA-200a/TFAM在MCF-7细胞对紫杉醇化疗敏感性中的作用。方法分别采用实时荧光定量PCR、蛋白印迹法检测不同浓度紫杉醇处理MCF-7细胞后mi R-200a、TFAM蛋白的表达差异;转染mi R-200a(或antimi R-200a)联合紫杉醇处理MCF-7细胞后,应用四甲基偶氮唑蓝(MTT)法和5-溴脱氧尿嘧啶核苷(Brd U)观察细胞增殖活力的变化;转染pc DNA3.1-TFAM质粒联合紫杉醇处理MCF-7细胞后,MTT和Brd U法检测细胞增殖活力的变化。结果在MCF-7细胞中,mi R-200a的表达量随紫杉醇浓度增加逐渐升高,而TFAM的表达量随紫杉醇浓度升高逐渐下降。紫杉醇与mi R-200a共同作用于MCF-7细胞,可增强紫杉醇对细胞增殖的抑制作用;紫杉醇与anti-mi R-200a共同作用于MCF-7细胞时,可减弱紫杉醇对细胞增殖的抑制作用;而紫杉醇与TFAM共同孵育MCF-7细胞时,可减弱紫杉醇对细胞增殖的抑制作用。结论 mi R-200a及TFAM参与调控紫杉醇对MCF-7细胞的化疗敏感性。 Objective To investigate the function of paclitaxel on chemo-sensitivity of MCF-7cells by regulating miR-200a/TFAMpathway.Methods The mRNA and protein expression of miR-200a and TFAM in MCF-7cells were detected by real-time PCR and Westernblot,respectively.After transfection of MCF-7cells with miR-200a mimics,anti-miR-200a or pcDNA3.1-TFAM plasmids under paclitaxeltreatment,MTT assay and BrdU assays were used to evaluate the cell proliferation of MCF-7cells.Results The expression of miR-200a in MCF-7cells increased after paclitaxel treatment in a dose-dependent manner,while the mRNA and protein expression of TFAMdecreased after paclitaxel treatment in a dose-dependent manner.MiR-200a mimics enhanced the inhibitory effect of paclitaxel on theproliferation of MCF-7cells,whereas anti-miR-200a attenuated the inhibitory effect of paclitaxel on MCF-7cell proliferation;TFAM alsoattenuated the inhibitory effect of paclitaxel on MCF-7cell proliferation.Conclusion MiR-200a and TFAM are involved in regulating thechemosensitivity MCF-7cells after paclitaxel treatment.
作者 姚佳 周恩相 徐峰 易文君 张丹华 邹琼燕 YAO Jia;ZHOU Enxiang;XU Feng;YI Wenjun;ZHANG Danhua;ZOU Qiongyan(Department of General Surgery, the Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China)
出处 《肿瘤药学》 CAS 2017年第5期528-533,544,共7页 Anti-Tumor Pharmacy
基金 湖南省自然科学基金(12JJ5064)
关键词 乳腺癌 microRNA-200a 线粒体转录因子A 紫杉醇 Breast cancer MicroRNA-200a Mitochondril transcription factor A Paclitaxel
  • 相关文献

参考文献2

二级参考文献62

  • 1李海霞,鲁艳明,温冬雪,张淑兰.凋亡诱导因子在宫颈癌组织中的表达及意义[J].中国医科大学学报,2009,38(4):268-269. 被引量:5
  • 2余果宇,江萍,李云峰,冯维杨.线粒体基因D—loop区在胃癌中的突变及多态性研究[J].昆明医学院学报,2007,28(5):8-12. 被引量:3
  • 3American Cancer Society. Cancer Facts & Figures 2013[ R]. At- lanta: American Cancer Society, 2013.
  • 4Early Breast Cancer Trialists' Collaborative Group ( EBCTCG ) ,Peto R, Davies C, et al. Comparisons between different polyche- motherapy regimens for early breast cancer: meta-analyses of long- term outcome among 100,000 women in 123 randomised trials [J]. Lancet, 2012, 379(9814) :432-444.
  • 5Osborne CK, Schiff R. Mechanisms of endocrine resistance in breast cancer[ J]. Annu Rev Med, 2011, 62:233-247.
  • 6Bartel DP. MicroRNAs : target recognition and regulatory functions [J]. Cell, 2009, 136(2) :215-233.
  • 7Pasquinelli AE. MicroRNAs and their targets: recognition, regu- lation and an emerging reciprocal relationship [ J ]. Nat Rev Genet, 2012, 13(4) :271-282.
  • 8Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic : progress in validating and targeting microRNAs for cancer therapy [ J]. Nat Rev Cancer, 2011, 11 (12) : 849 -864.
  • 9Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer[J]. Curr Genomics, 2010, 11(7) :537-561.
  • 10Farazi TA, Hoell JI, Morozov P, et al. MicroRNAs in human cancer[ J]. Adv Exp Med Biol, 2013, 774:1-20.

共引文献8

同被引文献46

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部